SCHEMBL23914290

SCHEMBL23914290

C=C1C(=O)O[C@H](c2cccnc2)[C@@H]1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
CYP3A4 P08684 3/20 0.41
THRB P10828 1/20 0.41
TSHR P16473 1/20 0.41
THPO P40225 1/20 0.41
MEN1 O00255 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP2A6 P11509 2/20 0.39
CYP11B2 P19099 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
CYP19A1 P11511 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23914375 0.80 BRD4 (0.39) KDM4EMEN1KMT2ANPSR1ALDH1A1
SCHEMBL14439399 0.80 BRD4 (0.39) KDM4EMEN1KMT2ANPSR1ALDH1A1
SCHEMBL14427628 0.80 BRD4 (0.39) KDM4EMEN1KMT2ANPSR1ALDH1A1
SCHEMBL10242861 0.73 GRM5 (0.46) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL15676069 0.73 GRM5 (0.46) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL10242864 0.73 GRM5 (0.46) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL9844930 0.72 CYP2A6 (0.49) CYP3A4ALDH1A1CYP2A6CYP11B2CHRNB2
SCHEMBL15744020 0.71 KDM4E (0.49) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL15744004 0.71 KDM4E (0.49) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL23914102 0.70 MAPT (0.44) CYP3A4THRBTSHRMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS MIF, LTA, MGAM KDM4E 2541/4885CYP3A4 772/4885THRB 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.